News

Press Release70% increase in Phase I advanced therapy clinical trials in the UK in 2024
Filter:AllGeneralRegulatory NewsNewsletterExternalManufacturingPress ReleaseSkills and TrainingChallenge Theme – PATChallenge Theme – AAVChallenge Theme – iPSCsNon ClinicalCommercialisation of Research
Year:All2025202420232022 →
Braintree Manufacturing Innovation Centre: A case study in GMP transformational changeBraintree Manufacturing Innovation Centre: A case study in GMP transformational changeCell and Gene Therapy Catapult annual review shows investment in the UK advanced therapy industry returned to growth in 2024Cell and Gene Therapy Catapult annual review shows investment in the UK advanced therapy industry returned to growth in 2024Regulatory Round-up - August 2024Regulatory Round-up - August 2024Regulatory Round-up - July 2024Regulatory Round-up - July 2024Challenge Theme R&D spotlight: Identifying potential targets to monitor and control differentiation of stem cells to haematopoietic progenitor cellsChallenge Theme R&D spotlight: Identifying potential targets to monitor and control differentiation of stem cells to haematopoietic progenitor cellsPatient first: Highlights from the RSM’s “Unveiling Gene Therapy: Transforming medical practice through ATMPs” eventPatient first: Highlights from the RSM’s “Unveiling Gene Therapy: Transforming medical practice through ATMPs” eventCGT Catapult establishes consortium to improve AAV formulationCGT Catapult establishes consortium to improve AAV formulationRegulatory Round-up - June 2024Regulatory Round-up - June 2024Plurify and the Cell and Gene Therapy Catapult to develop technology that improves purity of cell therapiesPlurify and the Cell and Gene Therapy Catapult to develop technology that improves purity of cell therapiesRegulatory Round-up - May 2024Regulatory Round-up - May 2024CATTI and the Cell and Gene Therapy Catapult to establish shared training standards for advanced therapies manufacturingCATTI and the Cell and Gene Therapy Catapult to establish shared training standards for advanced therapies manufacturingCGT Catapult establishing digital and automation testbeds to enable the scale-up of advanced therapy manufacturingCGT Catapult establishing digital and automation testbeds to enable the scale-up of advanced therapy manufacturing